Good morning, everyone. A spot of rain is falling on the Pharmalot corporate campus this morning, but our spirits remain sunny. After all, as the Morning Mayor used to say: Every brand new day should be unwrapped like a precious gift. So while you tug on the ribbon, please join us for a cup of stimulation and take a moment to scan the news of the world. Hope your day goes well and you remain dry...
Amgen Says Xvega Delays Prostate Cancer Bone Pain (Reuters)
Merck To Close Inspire HQ And Lay Off Workers (Raleigh News-Observer)
Gingrich Says Alzheimer's Research Will Save US Money (Associated Press)
Pfizer Lung Cancer Drug To Get FDA Priority Review (Reuters)
Mylan Must Pay $24M To Ipsen Over Pill Marketing (Bloomberg News)
Actos Diabetes Drug Linked To Bladder Cancer (Reuters)
Alexion To Expand Plant And Add Jobs In Rhode Island (WPRI)
Glaxo Kenyan Unit To Cut Prices Of Essential Drugs By Half (Bloomberg News)
Family Loses Fight Against Sanofi Over Epilepsy Drug (Bognor Regis Observer)
Genzyme Sues Allergan Over Juvederm Patent Royalties (Bloomberg News)
Quintiles Strikes Genomics Partnership (Outsourcing Pharma)
EDITOR’S NOTE: Please check this post for updates throughout the morning
rain pic thx to sterlic on flickr
5 Comments
Gingrich should go back to his old history teacjing job at Tulane. I hear he was pretty good-probably the only job he was ever good at.
Industry Insider, Gingrich received his degree from Tulane, but he taught at two topnotch institutions -- Kennesaw State and West Georgia College.
Thanks, Reality Check. I forgot about those two Harvards of the South.
Let's hope that President Gingrich's education policy is not based on the title of his PhD dissertation from Tulane: "Belgian Education Policy in the Congo: 1945–1960".
It would be instructive for any incoming President to appreciate the educational policies of 'overseas'. You know, the ones that are teaching functional studies with practical applications, and those boring old subjects that might actaully translate innovation into job creation and ultimately wealth.